BLTE

Belite Bio Inc ADR (BLTE)

US
$ 81.08-1.59%

Price Chart

Key Statistics

Market Cap
$ 1.95B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
127.12K
52W High
$ 86.53
52W Low
$ 43.70
Dividend Yield
0.00%
Beta
-1.45

Technicals

50-Day MA
61.0342
200-Day MA
60.9847
52 Week High
86.53
52 Week Low
43.7

About BLTE

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medic.

Employees
25
Headquarters
San Diego, CA
CEO
Dr. Yu-Hsin Lin M.B.A., Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
GNW
Genworth Financial ...
$ 7.79
13.89
GPMT
Granite Point Mortg...
$ 2.56
11.30
JKS
JinkoSolar Holding ...
$ 20.47
6.78
RMAX
RE/MAX Holdings Inc...
$ 8.27
6.71
GTN
Gray Television Inc...
$ 4.17
4.77

Top Losers

Symbol/Name
LTP
% Chg
ALL
Allstate Corporatio...
$ 192.70
-2.77
HAL
Halliburton Company...
$ 22.41
-2.61
UBS
UBS Group AG Regist...
$ 30.81
-2.47
HL
Hecla Mining Compan...
$ 5.95
-2.14
TEF
Telefonica SA Commo...
$ 5.25
-1.69